Ted M. Ross - Publications

University of Pittsburgh, Pittsburgh, PA, United States 
Immunology, Microbiology Biology

118 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Bissel SJ, Carter CE, Wang G, Johnson SK, Lashua LP, Kelvin A, Wiley CA, Ghedin E, Ross TM. Age-related pathology associated with H1N1 A/California/07/2009 influenza virus infection. The American Journal of Pathology. PMID 31585069 DOI: 10.1016/j.ajpath.2019.08.017  0.4
2017 Keef E, Zhang LA, Swigon D, Urbano A, Ermentrout GB, Matuszewski M, Toapanta FR, Ross TM, Parker RS, Clermont G. Discrete dynamical modeling of influenza infection suggests age-dependent differences in immunity. Journal of Virology. PMID 28904202 DOI: 10.1128/JVI.00395-17  0.8
2016 Wong TM, Petrovsky N, Bissel SJ, Wiley CA, Ross TM. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Human Vaccines & Immunotherapeutics. 1-10. PMID 27215855 DOI: 10.1080/21645515.2016.1162931  0.4
2016 Kaynar AM, Nowalk MP, Lin CJ, Moehling KK, Susick M, Bakalov V, Pitt BR, Bain DJ, Ross TM, Saul SG, Zimmerman RK. Are plasma mineral levels related to antibody response to influenza vaccination in older adults? Human Vaccines & Immunotherapeutics. 0. PMID 26751915 DOI: 10.1080/21645515.2015.1113358  1
2015 Wiley CA, Bhardwaj N, Ross TM, Bissel SJ. Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus. Brain Pathology (Zurich, Switzerland). 25: 634-50. PMID 26276027 DOI: 10.1111/bpa.12281  1
2015 Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Journal of Virology. 89: 10612-24. PMID 26269188 DOI: 10.1128/JVI.01526-15  1
2015 Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR, Streblow DN, Haddad EK, Trautmann L, Ross T, Lin R, Hiscott J. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists. Journal of Virology. 89: 8011-25. PMID 26018150 DOI: 10.1128/JVI.00845-15  1
2015 Price I, Mochan-Keef ED, Swigon D, Ermentrout GB, Lukens S, Toapanta FR, Ross TM, Clermont G. The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study. Journal of Theoretical Biology. 374: 83-93. PMID 25843213 DOI: 10.1016/j.jtbi.2015.03.017  1
2015 Crevar CJ, Carter DM, Lee KY, Ross TM. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades. Human Vaccines & Immunotherapeutics. 11: 572-83. PMID 25671661 DOI: 10.1080/21645515.2015.1012013  1
2015 Nace DA, Lin CJ, Ross TM, Saracco S, Churilla RM, Zimmerman RK. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. The Journal of Infectious Diseases. 211: 1915-24. PMID 25525051 DOI: 10.1093/infdis/jiu622  1
2015 Carter DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, Isakova-Sivak I, Rudenko L, Ross TM. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine. Vaccine. 33: 108-16. PMID 25448100 DOI: 10.1016/j.vaccine.2014.11.008  1
2014 Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, ... ... Ross TM, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proceedings of the National Academy of Sciences of the United States of America. 111: 15798-803. PMID 25331901 DOI: 10.1073/pnas.1409171111  1
2014 Khurana S, Coyle EM, Verma S, King LR, Manischewitz J, Crevar CJ, Carter DM, Ross TM, Golding H. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine. Vaccine. 32: 6421-32. PMID 25284811 DOI: 10.1016/j.vaccine.2014.09.049  1
2014 Kling HM, Nau GJ, Ross TM, Evans TG, Chakraborty K, Empey KM, Flynn JL. Challenges and future in vaccines, drug development, and immunomodulatory therapy. Annals of the American Thoracic Society. 11: S201-10. PMID 25148426 DOI: 10.1513/AnnalsATS.201401-036PL  1
2014 Ross TM, Pereira LE, Luckay A, McNicholl JM, García-Lerma JG, Heneine W, Eugene HS, Pierce-Paul BR, Zhang J, Hendry RM, Smith JM. A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunity. Aids Research and Human Retroviruses. 30: 1072-81. PMID 24914761 DOI: 10.1089/AID.2014.0030  1
2014 Kirchenbaum GA, Ross TM. Eliciting broadly protective antibody responses against influenza. Current Opinion in Immunology. 28: 71-6. PMID 24632083 DOI: 10.1016/j.coi.2014.02.005  1
2014 Ross TM, Lin CJ, Nowalk MP, Huang HH, Spencer SM, Shay DK, Sambhara S, Sundaram ME, Friedrich T, Sauereisen S, Bloom CE, Zimmerman RK. Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age. Human Vaccines & Immunotherapeutics. 10: 1195-203. PMID 24614078 DOI: 10.4161/hv.28313  1
2014 De Groot AS, Moise L, Liu R, Gutierrez AH, Terry F, Koita OA, Ross TM, Martin W. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Human Vaccines & Immunotherapeutics. 10: 256-62. PMID 24525618 DOI: 10.4161/hv.28135  1
2014 Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzmán CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics. Journal of Virology. 88: 4123-31. PMID 24478442 DOI: 10.1128/JVI.03644-13  1
2014 Soloff AC, Bissel SJ, Junecko BF, Giles BM, Reinhart TA, Ross TM, Barratt-Boyes SM. Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates. The Journal of Infectious Diseases. 209: 2012-6. PMID 24403559 DOI: 10.1093/infdis/jiu009  1
2014 Bissel SJ, Wang G, Carter DM, Crevar CJ, Ross TM, Wiley CA. H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis. Journal of Virology. 88: 3077-91. PMID 24371072 DOI: 10.1128/JVI.01840-13  1
2014 Gopal R, Rangel-Moreno J, Fallert Junecko BA, Mallon DJ, Chen K, Pociask DA, Connell TD, Reinhart TA, Alcorn JF, Ross TM, Kolls JK, Khader SA. Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection. The American Journal of Pathology. 184: 55-63. PMID 24183780 DOI: 10.1016/j.ajpath.2013.09.012  1
2013 McHugh KJ, Mandalapu S, Kolls JK, Ross TM, Alcorn JF. A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity. Plos One. 8: e82865. PMID 24324838 DOI: 10.1371/journal.pone.0082865  1
2013 Moncla LH, Ross TM, Dinis JM, Weinfurter JT, Mortimer TD, Schultz-Darken N, Brunner K, Capuano SV, Boettcher C, Post J, Johnson M, Bloom CE, Weiler AM, Friedrich TC. A novel nonhuman primate model for influenza transmission. Plos One. 8: e78750. PMID 24244352 DOI: 10.1371/journal.pone.0078750  1
2013 Moise L, Tassone R, Latimer H, Terry F, Levitz L, Haran JP, Ross TM, Boyle CM, Martin WD, De Groot AS. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice. Human Vaccines & Immunotherapeutics. 9: 2060-8. PMID 24045788 DOI: 10.4161/hv.26511  1
2013 Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. The Journal of Experimental Medicine. 210: 1493-500. PMID 23857983 DOI: 10.1084/jem.20130212  1
2013 Limberis MP, Adam VS, Wong G, Gren J, Kobasa D, Ross TM, Kobinger GP, Tretiakova A, Wilson JM. Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Science Translational Medicine. 5: 187ra72. PMID 23720583 DOI: 10.1126/scitranslmed.3006299  1
2013 Eugene HS, Pierce-Paul BR, Cragio JK, Ross TM. Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge. Virology Journal. 10: 102. PMID 23548077 DOI: 10.1186/1743-422X-10-102  1
2013 León AJ, Banner D, Xu L, Ran L, Peng Z, Yi K, Chen C, Xu F, Huang J, Zhao Z, Lin Z, Huang SH, Fang Y, Kelvin AA, Ross TM, et al. Sequencing, annotation, and characterization of the influenza ferret infectome. Journal of Virology. 87: 1957-66. PMID 23236062 DOI: 10.1128/JVI.02476-12  1
2013 Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, Cherry JL, Lipman DJ, Ross TM. Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. Journal of Virology. 87: 1400-10. PMID 23115287 DOI: 10.1128/JVI.02257-12  1
2013 Larionova N, Kiseleva I, Isakova-Sivak I, Rekstin A, Dubrovina I, Bazhenova E, Ross TM, Swayne D, Gubareva L, Tsvetnitsky V, Fedorova E, Doroshenko E, Rudenko L. Live attenuated influenza vaccines against highly pathogenic H5N1avian influenza: Development and preclinical characterization Journal of Vaccines and Vaccination. 4. DOI: 10.4172/2157-7560.1000208  1
2012 Verma S, Dimitrova M, Munjal A, Fontana J, Crevar CJ, Carter DM, Ross TM, Khurana S, Golding H. Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies. Journal of Virology. 86: 12283-93. PMID 22951833 DOI: 10.1128/JVI.01596-12  1
2012 Carter DM, Lu HR, Bloom CE, Crevar CJ, Cherry JL, Lipman DJ, Ross TM. Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains. Plos One. 7: e39435. PMID 22815705 DOI: 10.1371/journal.pone.0039435  1
2012 Giles BM, Crevar CJ, Carter DM, Bissel SJ, Schultz-Cherry S, Wiley CA, Ross TM. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. The Journal of Infectious Diseases. 205: 1562-70. PMID 22448011 DOI: 10.1093/infdis/jis232  1
2012 Soloff AC, Weirback HK, Ross TM, Barratt-Boyes SM. Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection. Comparative Immunology, Microbiology and Infectious Diseases. 35: 309-17. PMID 22421538 DOI: 10.1016/j.cimid.2012.01.012  1
2012 Giles BM, Ross TM. Computationally optimized antigens to overcome influenza viral diversity. Expert Review of Vaccines. 11: 267-9. PMID 22380818 DOI: 10.1586/erv.12.3  1
2012 Verma N, Dimitrova M, Carter DM, Crevar CJ, Ross TM, Golding H, Khurana S. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children. Journal of Virology. 86: 5515-22. PMID 22379097 DOI: 10.1128/JVI.07085-11  1
2012 McBurney SP, Landucci G, Forthal DN, Ross TM. Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine. Aids Research and Human Retroviruses. 28: 1063-72. PMID 22214267 DOI: 10.1089/AID.2011.0351  1
2012 Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. Clinical and Vaccine Immunology : Cvi. 19: 128-39. PMID 22190399 DOI: 10.1128/CVI.05533-11  1
2012 Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM. Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice. Journal of Virology. 86: 1500-13. PMID 22130546 DOI: 10.1128/JVI.06034-11  0.4
2012 Wiley CA, Carter DM, Ross TM, Bissel SJ. Absence of fetal transmission of H1N1 despite severe maternal infection. Influenza and Other Respiratory Viruses. 6: e1. PMID 22103260 DOI: 10.1111/j.1750-2659.2011.00310.x  1
2012 Ross TM, Bhardwaj N, Bissel SJ, Hartman AL, Smith DR. Animal models of Rift Valley fever virus infection. Virus Research. 163: 417-23. PMID 22086058 DOI: 10.1016/j.virusres.2011.10.023  1
2012 Schneider-Ohrum K, Ross TM. Virus-like particles for antigen delivery at mucosal surfaces. Current Topics in Microbiology and Immunology. 354: 53-73. PMID 21744306 DOI: 10.1007/82_2011_135  1
2012 Bissel SJ, Giles BM, Wang G, Olevian DC, Ross TM, Wiley CA. Acute murine H5N1 influenza A encephalitis. Brain Pathology (Zurich, Switzerland). 22: 150-8. PMID 21714828 DOI: 10.1111/j.1750-3639.2011.00514.x  1
2011 Ross TM, Hairong L, Chia BS, Hill E, Weirback H, Zimmer S. Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA. Plos Currents. 3: RRN1265. PMID 22037352 DOI: 10.1371/currents.RRN1265  1
2011 Schneider-Ohrum K, Giles BM, Weirback HK, Williams BL, DeAlmeida DR, Ross TM. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice. Vaccine. 29: 9081-92. PMID 21963872 DOI: 10.1016/j.vaccine.2011.09.051  1
2011 Tang XC, Lu HR, Ross TM. Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge. Viral Immunology. 24: 311-9. PMID 21830902 DOI: 10.1089/vim.2011.0016  1
2011 Zinman G, Brower-Sinning R, Emeche CH, Ernst J, Huang GT, Mahony S, Myers AJ, O'Dee DM, Flynn JL, Nau GJ, Ross TM, Salter RD, Benos PV, Bar Joseph Z, Morel PA. Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque. Plos One. 6: e22401. PMID 21789257 DOI: 10.1371/journal.pone.0022401  1
2011 Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Mathematical Biosciences. 231: 186-96. PMID 21385589 DOI: 10.1016/j.mbs.2011.03.005  1
2011 Giles BM, Ross TM. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine. 29: 3043-54. PMID 21320540 DOI: 10.1016/j.vaccine.2011.01.100  1
2011 Petrovsky N, Ross TM. Challenges in improving influenza vaccine protection in the elderly. Expert Review of Vaccines. 10: 7-11. PMID 21162614 DOI: 10.1586/erv.10.153  1
2011 Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, Castro M, Wenzel S, Erzurum SC, Fitzpatrick AM, Teague WG, Jarjour N, Moore WC, Sumino K, Simeone S, Ratanamaneechat S, ... ... Ross TM, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. The Journal of Allergy and Clinical Immunology. 127: 130-7, 137.e1-3. PMID 21145578 DOI: 10.1016/j.jaci.2010.11.014  1
2011 Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. Journal of Virology. 85: 1246-56. PMID 21084473 DOI: 10.1128/JVI.02107-10  1
2011 Ross TM, Bhardwaj N, Eugene HS, Giles BM, McBurney SP, Rossi SL, Schneider-Ohrum K, Tang XC. Virus-Like Particle Vaccines: Advantages and Challenges Development of Vaccines: From Discovery to Clinical Testing. 97-124. DOI: 10.1002/9781118023648.ch4  1
2010 Tang XC, Lu HR, Ross TM. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine. 28: 6821-31. PMID 20727393 DOI: 10.1016/j.vaccine.2010.08.040  1
2010 Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, Zimmerman RK, Ostroff SM, Lee BY, Burke DS, Ross TM. Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. Plos One. 5: e11601. PMID 20644650 DOI: 10.1371/journal.pone.0011601  1
2010 Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. Plos One. 5: e11548. PMID 20634959 DOI: 10.1371/journal.pone.0011548  1
2010 Bhardwaj N, Heise MT, Ross TM. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. Plos Neglected Tropical Diseases. 4: e725. PMID 20582312 DOI: 10.1371/journal.pntd.0000725  1
2010 Ross TM. Dengue virus. Clinics in Laboratory Medicine. 30: 149-60. PMID 20513545 DOI: 10.1016/j.cll.2009.10.007  1
2010 Rossi SL, Ross TM, Evans JD. West Nile virus. Clinics in Laboratory Medicine. 30: 47-65. PMID 20513541 DOI: 10.1016/j.cll.2009.10.006  1
2010 Dunn MD, Rossi SL, Carter DM, Vogt MR, Mehlhop E, Diamond MS, Ross TM. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice. Virology Journal. 7: 95. PMID 20462412 DOI: 10.1186/1743-422X-7-95  1
2010 Rowe T, León AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, ... Ross TM, et al. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology. 401: 257-65. PMID 20334888 DOI: 10.1016/j.virol.2010.02.020  1
2010 Craigo JK, Ross TM. Animal lentiviruses. Editorial. Current Hiv Research. 8: 1. PMID 20238449  1
2010 Ross T, Zimmer S, Burke D, Crevar C, Carter D, Stark J, Giles B, Zimmerman R, Ostroff S, Lee B. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. Plos Currents. 2: RRN1148. PMID 20191082 DOI: 10.1371/currents.RRN1148  1
2010 Toapanta FR, DeAlmeida DR, Dunn MD, Ross TM. C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. Immunology Letters. 129: 32-8. PMID 20064559 DOI: 10.1016/j.imlet.2009.12.022  1
2010 Craigo JK, Ross TM. Current HIV Research: Editorial Current Hiv Research. 8: 1. DOI: 10.2174/157016210790416433  1
2009 Toapanta FR, Ross TM. Impaired immune responses in the lungs of aged mice following influenza infection. Respiratory Research. 10: 112. PMID 19922665 DOI: 10.1186/1465-9921-10-112  1
2009 Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. Critical role of IL-17RA in immunopathology of influenza infection. Journal of Immunology (Baltimore, Md. : 1950). 183: 5301-10. PMID 19783685 DOI: 10.4049/jimmunol.0900995  1
2009 Ross TM, Mahmood K, Crevar CJ, Schneider-Ohrum K, Heaton PM, Bright RA. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. Plos One. 4: e6032. PMID 19554101 DOI: 10.1371/journal.pone.0006032  1
2009 McBurney SP, Ross TM. Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine. 27: 4337-49. PMID 19389453 DOI: 10.1016/j.vaccine.2009.04.032  1
2009 Brower-Sinning R, Carter DM, Crevar CJ, Ghedin E, Ross TM, Benos PV. The role of RNA folding free energy in the evolution of the polymerase genes of the influenza A virus. Genome Biology. 10: R18. PMID 19216739 DOI: 10.1186/gb-2009-10-2-r18  1
2009 Sodora DL, Ross TM. Simian immunodeficiency virus pathogenesis. Current Hiv Research. 7: 1. PMID 19149548  1
2009 Sodora DL, Ross TM. Editorial Current Hiv Research. 7: 1. DOI: 10.2174/157016209787048555  1
2008 McBurney SP, Ross TM. Viral sequence diversity: challenges for AIDS vaccine designs. Expert Review of Vaccines. 7: 1405-17. PMID 18980542 DOI: 10.1586/14760584.7.9.1405  1
2008 Crevar CJ, Ross TM. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. Virology Journal. 5: 131. PMID 18957098 DOI: 10.1186/1743-422X-5-131  1
2008 Movsesyan N, Mkrtichyan M, Petrushina I, Ross TM, Cribbs DH, Agadjanyan MG, Ghochikyan A. DNA epitope vaccine containing complement component C3d enhances anti-amyloid-beta antibody production and polarizes the immune response towards a Th2 phenotype. Journal of Neuroimmunology. 205: 57-63. PMID 18838175 DOI: 10.1016/j.jneuroim.2008.08.016  1
2008 Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine. 26: 5393-9. PMID 18706956 DOI: 10.1016/j.vaccine.2008.07.084  1
2008 Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine. 26: 3352-61. PMID 18468740 DOI: 10.1016/j.vaccine.2008.03.055  1
2008 Balin SJ, Ross TM, Platt JL, Cascalho M. HIV genes diversify in B cells. Current Hiv Research. 6: 10-8. PMID 18288970 DOI: 10.2174/157016208783571919  1
2008 Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. Plos One. 3: e1501. PMID 18231588 DOI: 10.1371/journal.pone.0001501  1
2008 Mkrtichyan M, Ghochikyan A, Movsesyan N, Karapetyan A, Begoyan G, Yu J, Glenn GM, Ross TM, Agadjanyan MG, Cribbs DH. Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization. Dna and Cell Biology. 27: 19-24. PMID 17961074 DOI: 10.1089/dna.2007.0639  1
2007 Cole KS, Ross TM. Antibody neutralization. Current Hiv Research. 5: 505-6. PMID 18045107 DOI: 10.2174/157016207782418551  1
2007 Karkhanis LU, Ross TM. Mucosal vaccine vectors: replication-competent versus replication-deficient poxviruses. Current Pharmaceutical Design. 13: 2015-23. PMID 17627535 DOI: 10.2174/138161207781039832  1
2007 McBurney SP, Ross TM. Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines. Current Pharmaceutical Design. 13: 1957-64. PMID 17627529 DOI: 10.2174/138161207781039841  1
2007 Toapanta FR, Craigo JK, Montelaro RC, Ross TM. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Current Hiv Research. 5: 199-209. PMID 17346134 DOI: 10.2174/157016207780077057  1
2007 Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. 25: 3871-8. PMID 17337102 DOI: 10.1016/j.vaccine.2007.01.106  1
2007 McBurney SP, Young KR, Ross TM. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology. 358: 334-46. PMID 17011011 DOI: 10.1016/j.virol.2006.08.032  1
2007 Ross TM. Editorial: Vaccines and immunity Current Pharmaceutical Design. 13: 1955. DOI: 10.2174/138161207781039823  1
2006 Toapanta FR, Ross TM. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunologic Research. 36: 197-210. PMID 17337780 DOI: 10.1385/IR:36:1:197  1
2006 McBurney SP, Young KR, Nwaigwe CI, Soloff AC, Cole KS, Ross TM. Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. Current Hiv Research. 4: 475-84. PMID 17073623 DOI: 10.2174/157016206778560018  1
2006 Young KR, McBurney SP, Karkhanis LU, Ross TM. Virus-like particles: designing an effective AIDS vaccine. Methods (San Diego, Calif.). 40: 98-117. PMID 16997718 DOI: 10.1016/j.ymeth.2006.05.024  1
2006 Bower JF, Ross TM. A minimum CR2 binding domain of C3d enhances immunity following vaccination. Advances in Experimental Medicine and Biology. 586: 249-64. PMID 16893077 DOI: 10.1007/0-387-34134-X_17  1
2006 Bower JF, Li Y, Wyatt R, Ross TM. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Vaccine. 24: 5442-51. PMID 16621193 DOI: 10.1016/j.vaccine.2006.03.063  1
2006 Young KR, Ross TM. Elicitation of immunity to HIV type 1 Gag is determined by Gag structure. Aids Research and Human Retroviruses. 22: 99-108. PMID 16438652 DOI: 10.1089/aid.2006.22.99  1
2005 Bower JF, Sanders KL, Ross TM. C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences. Current Hiv Research. 3: 191-8. PMID 15853723 DOI: 10.2174/1570162053506937  1
2004 Young KR, Teal BE, Brooks Y, Green TD, Bower JF, Ross TM. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies. Aids Research and Human Retroviruses. 20: 1259-68. PMID 15588348 DOI: 10.1089/0889222042545063  1
2004 Ho PT, Teal BE, Ross TM. Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity. Virology. 329: 109-18. PMID 15476879 DOI: 10.1016/j.virol.2004.07.028  1
2004 Bower JF, Green TD, Ross TM. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Virology. 328: 292-300. PMID 15464849 DOI: 10.1016/j.virol.2004.07.031  1
2004 Young KR, Smith JM, Ross TM. Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle. Virology. 327: 262-72. PMID 15351214 DOI: 10.1016/j.virol.2004.07.009  1
2004 Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. Journal of Immunology (Baltimore, Md. : 1950). 172: 5833-7. PMID 15128761  1
2004 Bower JF, Yang X, Sodroski J, Ross TM. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. Journal of Virology. 78: 4710-9. PMID 15078953 DOI: 10.1128/JVI.78.9.4710-4719.2004  1
2004 Toapanta FR, Ross TM. Mouse strain-dependent differences in enhancement of immune responses by C3d. Vaccine. 22: 1773-81. PMID 15068861 DOI: 10.1016/j.vaccine.2003.10.050  1
2004 Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model. Vaccine. 22: 1764-72. PMID 15068860 DOI: 10.1016/j.vaccine.2003.09.054  1
2003 Ghochikyan A, Vasilevko V, Petrushina I, Movsesyan N, Babikyan D, Tian W, Sadzikava N, Ross TM, Head E, Cribbs DH, Agadjanyan MG. Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene. European Journal of Immunology. 33: 3232-41. PMID 14635031 DOI: 10.1002/eji.200324000  1
2003 Watanabe I, Ross TM, Tamura S, Ichinohe T, Ito S, Takahashi H, Sawa H, Chiba J, Kurata T, Sata T, Hasegawa H. Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine. 21: 4532-8. PMID 14575764 DOI: 10.1016/S0264-410X(03)00510-3  1
2003 Young KR, Ross TM. Particle-based vaccines for HIV-1 infection. Current Drug Targets. Infectious Disorders. 3: 151-69. PMID 12769792 DOI: 10.2174/1568005033481213  1
2003 Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology. 308: 270-8. PMID 12706077 DOI: 10.1016/S0042-6822(03)00008-4  1
2003 Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine. 21: 902-14. PMID 12547601 DOI: 10.1016/S0264-410X(02)00539-X  1
2003 Green TD, Montefiori DC, Ross TM. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. Journal of Virology. 77: 2046-55. PMID 12525639 DOI: 10.1128/JVI.77.3.2046-2055.2003  1
2001 Green TD, Newton BR, Rota PA, Xu Y, Robinson HL, Ross TM. C3d enhancement of neutralizing antibodies to measles hemagglutinin Vaccine. 20: 242-248. PMID 11567770 DOI: 10.1016/S0264-410X(01)00266-3  1
2001 Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins Aids Research and Human Retroviruses. 17: 829-835. PMID 11429124 DOI: 10.1089/088922201750252025  1
2000 Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge Nature Immunology. 1: 127-131. PMID 11248804 DOI: 10.1038/77802  1
2000 Ross TM, Narayan M, Fang ZY, Minella AC, Green PL. Human T-cell leukemia virus type 2 Tax mutants that selectively abrogate NFκB or CREB/ATF activation fail to transform primary human T cells Journal of Virology. 74: 2655-2662. PMID 10684280 DOI: 10.1128/JVI.74.6.2655-2662.2000  1
1999 Ross TM, Bieniasz PD, Cullen BR. Role of chemokine receptors in HIV-1 infection and pathogenesis Advances in Virus Research. 52: 233-267. PMID 10384237 DOI: 10.1016/S0065-3527(08)60300-0  1
1999 Ross TM, Oran AE, Cullen BR. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein Current Biology. 9: 613-621. PMID 10375525 DOI: 10.1016/S0960-9822(99)80283-8  1
1998 Ross TM, Cullen BR. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop Proceedings of the National Academy of Sciences of the United States of America. 95: 7682-7686. PMID 9636210 DOI: 10.1073/pnas.95.13.7682  1
1998 Mulloy JC, Migone TS, Ross TM, Ton N, Green PL, Leonard WJ, Franchini G. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV- 2(pan-p)) transform T cells independently of Jak/STAT activation Journal of Virology. 72: 4408-4412. PMID 9557732  1
1997 Ross TM, Minella AC, Fang ZY, Pettiford SM, Green PL. Mutational analysis of human T-cell leukemia virus type 2 Tax. Journal of Virology. 71: 8912-7. PMID 9343258  1
Show low-probability matches.